Strengthening the Biological Weapons Convention and implications on the pharmaceutical and biotechnology industry

Current Opinion in Biotechnology

Volumn 9, Issue 3, 1998, Pages 312-318

  Zabriskie, Dane ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL WARFARE; BIOTECHNOLOGY; DRUG INDUSTRY; INTERNATIONAL COOPERATION; LAW; LAW ENFORCEMENT; POLICY; PRIORITY JOURNAL; REVIEW; WAR;

EID: 0031842021     PISSN: 09581669     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0958-1669(98)80066-9     Document Type: Article

References (35)

1. Cole LA. The Eleventh Plague. The Politics of Biological and Chemical Warfare. 1997;WH Freeman, New York.
2. Danzig R. Why should we be concerned about biological warfare? JAMA. 278:1997;431-432.
3. Simon JD. Biological terrorism: preparing to meet the threat. JAMA. 278:1997;428-430.
4. Nelan BW. America the vulnerable - a disaster is just waiting to happen if Iraq unleashes its poisons and germs. Time. 1997;49-51. November 24.
5. Ferguson JR. Biological weapons and US law. JAMA. 278:1997;357-360.
6. Dando M. Biological Warfare in the 21st Century. Biotechnology and the Proliferation of Biological Weapons. 1994;Brasset's, London.
7. Franz DR, Jahrling PB, Friedlander AM, McClain DJ, Hoover DL, Byrne WR, Pavlin JA, Christopher GW, Eitzen EM. Clinical recognition and management of patients exposed to biological warfare agents. JAMA. 278:1997;399-411.
8. Tucker JB. National health and medical services response to incidents of chemical and biological terrorism. JAMA. 278:1997;362-368.
9. Kaufmann AF, Meltzer ML, Schmid GP. The economic impact of a bioterrorist attack: are prevention and postattack intervention programs justifiable? Emerg Infect Dis. 3:1997;83-94.
10. Christopher GW, Cieslak TJ, Pavlin JA, Eitzen EM. Biological warfare: a historical perspective. JAMA. 278:1997;412-417.
11. Patrick WC III. 2. A history of biological and toxin warfare. Bailey KC. Proliferation. 1994;9-20 Lawrence Livermore National Laboratory, Berkeley.
12. Poupard JA, Miller LA. Biological warfare. Lederberg J. Encyclopedia of Microbiology. 1:1992;297-308 Academic Press, London.
13. Abramova FA, Grinberg LM, Yampolskaya OV, Walker DH. Pathology of inhalation anthrax in 42 cases from the Sverdlovsk outbreak of 1979. Proc Natl Acad Sci USA. 96:1993;2291-2294.
14. Meselson M, Guillemin J, Hugh-Jones M, Langmir A, Popova I, Shelokov A, Yampolskaya O. The Sverdlovsk anthrax outbreak of 1979. Science. 266:1994;1202-1208.
15. Zilinskas RA. Iraq's biological weapons. The past as future? JAMA. 278:1997;418-424.
16. Kadlec RP, Zelicoff AP, Vrtis AM. Biological weapons control: prospects and implications for the future. JAMA. 278:1997;351-356.
17. Geisser E. Strengthening the Biological Weapons Convention by Confidence-Building Measures. 1990;Oxford University Press, Oxford.
18. Lundin SJ. Views on Possible Verification Measures for the Biological Weapons Convention. 1991;Oxford University Press, Oxford.
19. Convention on the Prohibition of the Development, Production, Stockpiling and Use of Chemical Weapons and on Their Destruction. 1993;United States Arms Control and Disarmament Agency, Washington, DC.
20. Zilinskas RS. UNSCOM and the UNSCOM experience in Iraq. Polit Life Sci. 14:1995;230-235.
21. Lacy EJ. Tackling the biological weapon threat: the next proliferation challenge. Wash Quart. 17:1994;53-64.
22. Walker JR, Phillips AP, Miller L. 13. Verification of the biological and toxin weapons convention and the UK's practice compliance inspection programme: final report. Poole JB, Guthrie R. Verification 1996. Arms Control, Peacekeeping and the Environment. 1996;171-191 Westview Press, Boulder, Colorado.
23. Tucker JB. The Utility of Sampling and Analysis for Compliance Monitoring of the Biological Weapons Convention. Proceedings of the Monterey Institute of International Studies: 1996 October 7-8; Washington DC. 1997;Center for Global Security Research, Washington DC.
24. Zelicoff AP. The biological weapons convention: what is the role of sample collection in a legally-binding regime? Polit Life Sci. 14:1995;79-84.
25. Johnson-Winegar A. The role of declarations in UNSCOM's program in Iraq. Polit Life Sci. 14:1995;236-238.
26. Huxsoll DL. On-site inspection measures and interviews. Polit Life Sci. 14:1995;238-240.
27. Mohr AJ. Biologial sampling and analysis procedures for the United Nations special commission (UNSCOM) in Iraq. Polit Life Sci. 14:1995;240-243.
28. Franz DR. Inventory control of dual-use equipment. Polit Life Sci. 14:1995;244-247.
29. St-Onge AA. United Nations biological warfare inspectors in Iraq: implications for biological arms control - one Canadian's perspective. Polit Life Sci. 14:1995;259-262.
30. Wick CB. Strengthening the biological and toxin weapons convention: implications for US industry and research. SIM News. 45:1995;224-228.
31. Tucker JB. Remote monitoring of dual-capable biological facilities in Iraq. Polit Life Sci. 14:1995;247-254.
32. Zelicoff A. Be realistic about biological weapons. Wash Post. 1998, January 8.
33. Lebeda FJ. Deterrence of biological and chemical warfare: a review of policy options. Mil Med. 162:1997;156-160.
34. Selden Z. Assessing the biological weapons threat. Business Executives for National Security Special Report. 1997;3-20 Business Executives for National Security, Washington DC.
35. Latter R. Preventing the Proliferation of Biological Weapons. 1995;1-21. (ISBN 0-11-701520-2).